Total planned funding: $462,239,771
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $159,951,120 |
Mozambique | $60,655,143 |
Zambia | $39,642,586 |
Kenya | $29,962,683 |
Vietnam | $24,016,763 |
Tanzania | $20,679,140 |
Botswana | $13,399,117 |
Rwanda | $12,863,783 |
South Africa | $11,500,611 |
Burundi | $9,307,534 |
Haiti | $9,230,713 |
Côte d'Ivoire | $8,821,901 |
Democratic Republic of the Congo | $8,630,245 |
Papua New Guinea | $6,684,056 |
Uganda | $6,602,442 |
India | $6,300,954 |
Indonesia | $5,281,155 |
Cambodia | $5,250,000 |
Asia Regional Program | $3,654,954 |
Angola | $3,335,000 |
Ethiopia | $2,952,270 |
Caribbean Region | $2,717,206 |
Malawi | $2,610,000 |
Central America Region | $1,646,143 |
China | $1,500,000 |
Eswatini | $1,313,737 |
South Sudan | $1,051,916 |
Cameroon | $700,000 |
Dominican Republic | $700,000 |
Namibia | $450,000 |
Central Asia Region | $300,000 |
Thailand | $278,599 |
Lesotho | $250,000 |
Ghana | $0 |
Organizational Types
NGO | $454,569,771 |
Implementing Agency | $7,670,000 |
Program Areas
Care | $145,759,667 |
Treatment | $125,316,268 |
Prevention | $118,166,436 |
Governance and Systems | $40,822,907 |
Testing | $32,174,493 |
Budget Codes
HTXS: Treatment: Adult Treatment | $112,285,973 |
HBHC: Care: Adult Care and Support | $72,248,661 |
HKID: Care: Orphans and Vulnerable Children | $48,898,399 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $47,774,587 |
HVOP: Sexual Prevention: Other Sexual Prevention | $44,749,885 |
HVCT: Testing: HIV Testing and Counseling | $32,174,493 |
HLAB: Laboratory Infrastructure | $17,545,991 |
HVTB: Care: TB/HIV | $14,223,440 |
HVSI: Strategic Information | $11,990,642 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,503,523 |
OHSS: Health Systems Strengthening | $11,286,274 |
PDCS: Care: Pediatric Care and Support | $10,389,167 |
PDTX: Treatment: Pediatric Treatment | $9,607,011 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $7,072,619 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $6,248,191 |
HTXD: Treatment: ARV Drugs | $3,423,284 |
HMIN: Biomedical Prevention: Injection Safety | $627,051 |
HMBL: Biomedical Prevention: Blood Safety | $190,580 |
Top Partner Programs
FHI 360:
$462,239,771
View countries